175 results
Page 4 of 9
8-K
EX-99.1
l3tb2qycqh4nl
30 Mar 20
Dyadic Reports 2019 Year End Results and Recent Developments
4:46pm
8-K
EX-99.1
alwpd134 tfvnd3qia2
18 Mar 20
Other Events
5:06pm
8-K
EX-99.2
lap5epb
18 Mar 20
Other Events
5:06pm
8-K
EX-99.1
60bzqc uy0
25 Feb 20
Other Events
2:53pm
8-K
EX-99.1
1sxw 2byx3
24 Feb 20
Dyadic Announces New Milestone
9:29am
8-K
EX-99.2
ptqc6yjs
28 Jan 20
Other Events
4:35pm
8-K
EX-99.1
rya9lmvi6
28 Jan 20
Other Events
4:35pm
8-K
EX-99.1
jf3jvqkpd 79
6 Jan 20
Dyadic Reports Continued Positive Business Trends and Scientific Results in Fourth Quarter 2019
4:25pm
8-K
EX-99.1
zyjj1tr 730
25 Nov 19
Dyadic Announces Achieving Human Like Glycan Structures
4:11pm
8-K
EX-99.1
22k043 ioqf52
13 Nov 19
Dyadic Reports Third Quarter 2019 Results and
4:54pm
8-K
EX-99.1
bsw 7csrmm
13 Aug 19
Results of Operations and Financial Condition
4:29pm
8-K
EX-10.1
gdgoh0 1uhx1n
5 Jul 19
Dyadic Extends Research and Development Agreement with VTT
3:55pm
8-K
EX-99.1
l9r2x8w0reot3 x460
5 Jul 19
Dyadic Extends Research and Development Agreement with VTT
3:55pm
8-K
EX-99.1
ofqzh01z49
27 Jun 19
Dyadic Announces Appointment of Ping Rawson to CFO
4:37pm
8-K
EX-99.1
z98ey4xjag ii5rin
9 May 19
Dyadic Reports First Quarter Financial Results and Recent Developments
4:13pm
10-Q
d93zbl
9 May 19
Quarterly report
4:11pm
8-K
EX-99.1
umyb3 bvsqft
8 May 19
Dyadic and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products and Vaccines
4:26pm
8-K
EX-99.1
osj36ny2d6dz
8 May 19
Dyadic Announces Sub-Licensing Agreement with Alphazyme
3:15pm